Index Entries - Covid Index

1616 Results

Title	IS Publication Date
Quantifying the risk of SARS-CoV-2 reinfection over time	May 27, 2021
Quantitative evaluation of whether the Nobel-Prize-winning COVID-19 vaccine actually saved millions of lives	October 8, 2023
Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19)	June 19, 2020
Questions for a Covid-19 Commission	2023
Randomized trials - Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centers	June 21, 2022
Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1	November 12, 2021
Rapid Expert Consultation on the Effectiveness of Fabric Masks for the Covid-19 Pandemic	April 8, 2020
Rapid Response: Open letter from The BMJ to Mark Zuckerberg	December 17, 2021
Rapid Response: Psychosocial, biological, and immunological risks for children and pupils make long-term wearing of mouth masks difficult to maintain	September 9, 2020
Rapid Response: Why don't Covid-19 vaccine trials report statistics for the first 14 days?	March 16, 2021
Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination	October 8, 2021
Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland	August 3, 2022
Re-analysis on the statistical sampling biases of a mask promotion trial in Bangladesh: a statistical replication	September 15, 2022
React19
Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases	January 19, 2021
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2	June 1, 2021
Real Not Rare
Real REACTIONS - Non-profit support organization for the vaccine injured
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study	July 18, 2024
Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus	May 13, 2022
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus	August 2, 2019
Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations	March 26, 2021
Recurrence of Autoimmune Hepatitis After COVID-19 Vaccination	May 25, 2022
Recurrent Myocarditis Following COVID-19 Infection and the mRNA Vaccine	July 7, 2022
Reducing SARS-CoV-2 transmission in the UK: A behavioural science approach to identifying options for increasing adherence to social distancing and shielding vulnerable people	May 19, 2020
Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects	August 31, 2022
Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant Women	April 7, 2022
Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study	March 15, 2021
Remdesivir for COVID-19: real-time meta analysis of 79 studies	January 2025
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial	April 29, 2020
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial	September 14, 2021
Reply to Fung et al. on COVID‐19 vaccine case‐countingwindow biases overstating vaccine effectiveness	July 4, 2023
Report 12: The Global Impact of COVID-19 and Strategies for Mitigation and Suppression	March 26, 2020
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand	March 16, 2020
Report an Adverse Event to VAERS
Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review	September 20, 2016
Reports of acute adverse events in mRNA COVID‑19 vaccine recipients after the first and second doses in Japan	September 15, 2022
Reports Of Autopsies In VAERS And Associated Adverse Events Linked To Cause Of Death	February 4, 2025
Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden	August 19, 2024
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States	February 1, 2023
Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities	March 30, 2021
Research Letter: Acute Allergic Reactions to mRNA COVID-19 Vaccines	March 8, 2021
Research Letter: Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination	November 1, 2021
Research Letter: All-Cause Excess Mortality and COVID-19 - Related Mortality Among US Adults Aged 25-44 Years, March-July 2020	December 16, 2020
Research Letter: Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy	May 28, 2021
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk	September 26, 2022
Research Letter: Routine Surveillance and Vaccination on a University Campus During the Spread of the SARS-CoV-2 Omicron Variant	May 18, 2022
Responding to Covid‐19: How to Navigate a Public Health Emergency Legally and Ethically	March 26, 2020
Response to Critics of Lee & Broudy (2024) on the Toxicity and Self-Assembling Technology in Incubated Samples of Injecta	September 17, 2024
Response to Request for Information (RFI): COVID-19 Misinformation from Official Sources During the Pandemic	May 2, 2022

Page 23 of 33